1sr9: Difference between revisions

Revision as of 06:56, 28 July 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:1sr9.png

Template:STRUCTURE 1sr9

Crystal Structure of LeuA from Mycobacterium tuberculosisCrystal Structure of LeuA from Mycobacterium tuberculosis

Template:ABSTRACT PUBMED 15159544

About this StructureAbout this Structure

1SR9 is a Single protein structure of sequence from Mycobacterium tuberculosis. Full crystallographic information is available from OCA.

ReferenceReference

Crystal structure of LeuA from Mycobacterium tuberculosis, a key enzyme in leucine biosynthesis., Koon N, Squire CJ, Baker EN, Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8295-300. Epub 2004 May 24. PMID:15159544

Page seeded by OCA on Mon Jul 28 06:56:45 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:1sr9.gif|left|200px]]
+{{Seed}}
+[[Image:1sr9.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_1sr9|  PDB=1sr9  |  SCENE=  }}
-'''Crystal Structure of LeuA from Mycobacterium tuberculosis'''
+===Crystal Structure of LeuA from Mycobacterium tuberculosis===
-==Overview==
+<!--
-The leucine biosynthetic pathway is essential for the growth of Mycobacterium tuberculosis and is a potential target for the design of new anti-tuberculosis drugs. The crystal structure of alpha-isopropylmalate synthase, which catalyzes the first committed step in this pathway, has been determined by multiwavelength anomalous dispersion methods and refined at 2.0-A resolution in complex with its substrate alpha-ketoisovalerate. The structure reveals a tightly associated, domain-swapped dimer in which each monomer comprises an (alpha/beta)(8) TIM barrel catalytic domain, a helical linker domain, and a regulatory domain of novel fold. Mutational and crystallographic data indicate the latter as the site for leucine feedback inhibition of activity. Domain swapping enables the linker domain of one monomer to sit over the catalytic domain of the other, inserting residues into the active site that may be important in catalysis. The alpha-ketoisovalerate substrate binds to an active site zinc ion, adjacent to a cavity that can accommodate acetyl-CoA. Sequence and structural similarities point to a catalytic mechanism similar to that of malate synthase and an evolutionary relationship with an aldolase that catalyzes the reverse reaction on a similar substrate.
+The line below this paragraph, {{ABSTRACT_PUBMED_15159544}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 15159544 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_15159544}}
 ==About this Structure==
@@ Line 27: / Line 31: @@
 [[Category: Squire, C J.]]
 [[Category: Tim barrel]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 09:03:16 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 06:56:45 2008''